Stent makers fail to convince panel on differential pricing
New Delhi, Aug. 28 -- Premium coronary stents may remain out of reach for Indian patients, with stent manufacturers failing to convince an expert panel that their products are special enough to be kept out of price control....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.